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Abstract
Tetramers of the mammalian water channel aquaporin-4 (AQP4) assemble into square arrays and mediate bidirectional water transport across
the blood–brain interface. The aqp4 gene expresses two splicing isoforms. Only the shorter AQP4M23 isoform assembles into square arrays,
while the longer AQP4M1 isoform interferes with array formation, presumably due to the additional 22 N-terminal residues. To understand why
the N-terminus of AQP4M1 interferes with array formation, we constructed a series of N-terminal deletion mutants and examined their ability to
form square arrays in Chinese hamster ovary (CHO) cells using SDS-digested freeze fracture replica labeling. Mutants with deletions of less than
seventeen N-terminal residues did not form square arrays and showed dispersed immunogold labels against AQP4 molecules, whereas more
deletions led to the formation of square arrays labeled with immunogolds. Furthermore, mutagenic substitution of the two cysteine residues at the
position 13 and 17 in the N-terminus of AQP4M1 also resulted in the square array formation. Biochemical analysis and metabolic labeling of
transfected CHO cells revealed that the two N-terminal cysteines of AQP4M1 are palmitoylated. These results suggest that palmitoylation of the
N-terminal cysteines is the reason for the inability of AQP4M1 to form square arrays.
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Water channels of the aquaporin (AQP) family are found
from archaea to animals and plants [1]. Thirteen water channels
have been identified in humans, which fall into two classes:
aquaporins, the pure water channels, and aquaglyceroporins,
which in addition to water also permeate small, uncharged so-
lutes. The first structure of an AQP, human AQP1, was analyzed
by electron crystallography [2]. It revealed that each subunit in
the AQP1 tetramer contains six transmembrane helices and two
short helices forming a water selective pore. Although the per-Abbreviations: AQP, aquaporin; CHO, Chinese hamster ovary; IMP, intra-
membrane particle; SDS-FRL, SDS-digested freeze fracture replica labeling;
P-face, protoplasmic fracture face; E-face, exoplasmic fracture face; ABE,
acyl-biotinyl exchange; NEM, N-ethylmaleimide; AP, Alkaline Phosphatase
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the mammalian AQPs [3], other information is still lacking. For
example, while it has been established that the trafficking of
AQP2 from intracellular vesicles to the apical membrane in the
renal collecting duct is regulated by phosphorylation [4], little is
known about how the function, expression and distribution of
the other human AQPs are regulated.
AQP4 is a specific water channel that is predominantly ex-
pressed in the brain. More specifically, AQP4 is expressed in
ependymal cells and retinal Müller cells as well as in astrocytes,
in which AQP4 is localized to plasma membrane regions of glial
end-feet that face blood vessels and the pia [5]. The specific
localization of AQP4 appears to contribute to facilitate the bi-
directional water flow across blood–brain interfaces [6–8].
Early freeze fracture electron microscopy studies revealed pro-
minent arrays of orthogonally arranged intramembrane particles
(IMPs) in the perivascular membranes of astrocyte end-feet
[9]. Such square arrays have also been found in the basolateral
membranes of renal collecting ducts [10] and the sarcolemmas of
1182 H. Suzuki et al. / Biochimica et Biophysica Acta 1778 (2008) 1181–1189myofibers [11], both tissues that also express AQP4. Later
studies using immunogold labeling of freeze fracture replicas
provided direct evidence that AQP4 is the major constituent of
the square arrays [12]. While the function of these arrays in the
brain remains unclear, square arrays were reported to rapidly
shrink or even disappear after circulatory arrest [13], indicating
that the assembly of AQP4 tetramers into square arrays changes
in response to the physiological conditions of the water home-
ostasis in the brain.
AQP4 has two alternative splice variants resulting from
differential translation initiation either at the first methionine
(AQP4M1, 323 aa) or at the second methionine (AQP4M23,
301 aa) [14]. As a result, AQP4M1 has a 22 residues longer
N-terminus than AQP4M23. Endogenous AQP4 is considered
to form heterotetramers containing both isoforms in vivo, but
SDS-PAGE analysis showed that in rat brain and other tissues
AQP4M23 ismuchmore abundant thanAQP4M1 [15].While the
water permeabilities of AQP4M1 and AQP4M23 are likely to be
similar [14,15], freeze fracture analyses of CHO cells expressing
AQP4M1 or AQP4M23 revealed that the two isoforms have
different morphological properties. AQP4M23 can form large
square arrays, whereas AQP4M1 restricts the formation of square
arrays [16,17]. Co-expression of AQP4M1 and AQP4M23 leads
to square arrays that are similar in size to those seen in astrocytes,
implying that regulation mechanisms exist that may define the
size and disassembly efficiency of square arrays.
The structure of rat AQP4M23 was determined by electron
crystallography of two-dimensional (2D) crystals [18]. The
packing of the tetramers in the 2D crystals, which resembled
the one seen in in vivo square arrays, was stabilized by inter-
molecular interactions between amino acid residues of the trans-
membrane domains. This packing of AQP4 contrasted with that
of the AQP0 arrays, which were stabilized by lipid–protein
interactions [19–22]. The characteristic intermolecular interac-
tions in AQP4 crystals were mediated by Arg108 and Tyr250,
while further hydrophobic interactions were mediated byGly157,
Trp231, and Ile239, which are conserved in other AQPs. We
proposed a mechanism regulating array disassembly based on
competition experiments using peptides with Wild Type (WT)
and mutated sequences of the AQP4M1 N-terminus. Our results
suggested that Arg9, which is conserved in AQP4 proteins from
different species, was the key residue in the destabilization of
square arrays [18]. Since this idea was solely based on the
structure of AQP4 in 2D crystals, it was necessary to test this
hypothesis in living cells.
To elucidate the structural mechanism that regulates array
formation, we constructed systematic N-terminal deletion
mutants of AQP4 and examined their abilities to form square
arrays by using SDS-digested freeze fracture replica labeling
(SDS-FRL) [23] to directly visualize the distribution of AQP4
molecules in transiently transfected CHO cells. We identified
two cysteine residues, only present in the longer N-terminus of
AQP4M1, that are essential in disrupting the formation of square
arrays. Further biochemical studies revealed that the N-terminal
cysteines are post-translationally modified with palmitic acid.
We thus propose palmitoylation as a new mechanism regulating
the formation of AQP4 square arrays.2. Materials and methods
2.1. Chemicals and antibody
Paraformaldehyde was purchased from TAAB (Berkshire, UK), polyvinyl
formal (Formvar) from Okenshoji (Tokyo, Japan), [3H]-palmitic acid
(1.147 TBq/mmol) from PerkinElmer (Boston, MA, USA), and antibody
against the C-terminus of AQP4 (anti-AQP4CT: rabbit polyclonal IgG, SC-
20812) from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
2.2. Construction of expression vectors
cDNAs for WT rat AQP4M1 and AQP4M23 were cloned from a rat brain
cDNA library by PCR amplification. N-terminal deletion mutants were
constructed by PCR from WT rat AQP4M1 cDNA and then subcloned into the
pGEM-T Easy Vector (Promega). Cysteine substitutions were introduced using
the QuickChange II Site-Directed Mutagenesis Kit (Stratagene). A 5′-KOZAK
sequence (GCCACC) was added to each AQP4 construct just before the start
codon. All constructs were confirmed by DNA sequencing. For expression,
AQP4 constructs were cloned into the pcDNA3.1 (+) Vector (Invitrogen).
2.3. Expression
CHO-K1 cells were cultured in Dulbecco's modified Eagle's medium
(DMEM) (SIGMA) containing 10% fetal bovine serum (BioWhittaker) and
antibiotics. Cells were transfected with expression vectors using Lipofectamine
2000 according to the manufacturer's protocol (Invitrogen) with a slight
modification to lower the toxicity. Opti-MEM I (Invitrogen) was used as culture
medium during transfection and was replaced with serum-supplemented DMEM
2 h after transfection. For immunoblotting, transfected cells were harvested 24 h
after transfection, lysed with 1% 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate (CHAPS) (Dojindo, Kumamoto, Japan) in phosphate-buffered
saline (PBS: 9.7 mM sodium phosphate, 1.5 mM potassium phosphate, 137 mM
NaCl, 2.7 mM KCl, pH 7.4), and subjected to Western blot analysis with anti-
AQP4CT antibody. Cell lines stably expressing AQP4 constructs were selected
using 800 µg/ml Geneticin (Invitrogen) for 2 weeks after transfection.
2.4. SDS-FRL
SDS-FRL was performed as described previously [23,24] with the following
modifications. Cells transiently expressing AQP4 constructs were scraped 24 h
after transfection and cells stably expressing AQP4 constructs just before
confluence. The cells were pelleted in phosphate buffer (PB: 100 mM sodium
phosphate, pH 7.2), and fixed overnight at 37 °C with 4% formaldehyde (freshly
depolymerized from paraformaldehyde) in PB. Fixed cells were washed with PB
and cryo-protected by incubation in 30% glycerol in PB for 16 h at 4 °C. Cell
suspensions mounted on flat specimen carriers (ϕ 3 mm; Bal-Tec, Balzers,
Liechtenstein) were frozen by immersion in liquid nitrogen and fractured with a
cooled metal knife in a freeze-etching system (BAF060; Bal-Tec) at −120 °C.
The fractured faces were unidirectionally shadowed with platinum/carbon
(2 nm) at an angle of 60°, followed by rotational carbon evaporation (20 nm)
from the top. The pieces of replica were transferred to SDS digestion buffer
(2.5% SDS in 15 mM Tris–HCl, pH 8.3, 20% sucrose) and incubated for 20 min
at 121 °C in an autoclave. After cooling to room temperature, the replicas were
washed three times with washing buffer (25 mM Tris–HCl, pH 7.4, 137 mM
NaCl, 2.7 mM KCl, 0.1% Tween-20, 0.05% BSA, 0.05% NaN3), blocked for
30 min in blocking buffer (5% BSA in washing buffer), and incubated with anti-
AQP4CT antibody (0.4 µg/ml in blocking buffer) for 16 h at 4 °C. The replicas
were washed again three times with washing buffer, blocked for 30 min in
blocking buffer, and incubated with goat anti-rabbit IgG secondary antibodies
coupled to 15 nm gold particles (BBInternational, Cardiff, UK) (1:50 dilution in
blocking buffer) for 1 h at room temperature. The replicas were washed three
times with washing buffer, twice with distilled water, and mounted on 100-mesh
grids pre-coated with Formvar.
Fig. 1. Expression of ratAQP4 isoforms in CHO cells and SDS-FRL analysis. (A) Immunoblot of lysates of CHO cells transfected with AQP4M1, AQP4M23 or no
vector (control), probed with anti-AQP4CT antibody. The major bands are at the expected positions for the two AQP4 isoforms, while the minor bands would
correspond to dimers of the respective isoforms. (B) No immunolabeling is observed on the P-face of non-transfected CHO cells by SDS-FRL. Asterisks indicate
cross-fractured regions through protruding portions of the cells. (C and D) SDS-FRL images of the P-face (C) and the E-face (D) of CHO cells transfected with
AQP4M1. Immunogold particles are evenly distributed over the P-face, whereas the E-face shows the absence of square arrays and immunogold particles. (E and F)
SDS-FRL images of the P-face (E) and the E-face (F) of CHO cells transfected with AQP4M23. Immunogold particles on the P-face are exclusively found on the
square arrays. The E-face shows pit-like imprints of the square arrays. The smooth, featureless area shows the buffer region outside the cells. Scale bars are 200 nm.
Fig. 2. N-terminal deletion mutants of AQP4. (A) Amino acid sequences of
the N-termini of AQP4M1, AQP4M23 and mutants with increasingly long
N-terminal deletions. The number of the mutant indicates the position of the
initiation methionine relative to AQP4M1. (B) Immunoblot of lysates of CHO
cells transfected with the various N-terminal deletion mutants of AQP4, probed
with anti-AQP4CT antibody. The same amounts of cell lysates from 35-mm
dish cultures were loaded on the SDS-PAGE gel.
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Mild fixation of the cells with 2% formaldehyde for 30 min resulted in
deformation of the square arrays on the protoplasmic fracture face (P-face) and
the deposition of IMPs on the square array pits on the exoplasmic fracture face
(E-face). This suggested that inappropriate fixation conditions caused AQP4
molecules in square arrays to distribute randomly between the P-and E-faces.
Fixation with 2.5% glutaraldehyde showed similar morphology of the square
arrays to those obtained by overnight fixation with 4% formaldehyde at 37 °C
(data not shown), but glutaraldehyde fix is not suitable for SDS-FRL. To observe
the square arrays by SDS-FRL, it was thus essential to fix the cells overnight
with 4% formaldehyde at 37 °C. The antigenicity of AQP4 was preserved under
these fixation conditions.
2.6. Electron microscopy
Replica specimens were imaged in a JEM-1010 electron microscope (JEOL,
Tokyo, Japan) equipped with a 2K slow-scan CCD camera (Gatan, Warrendale,
PA, USA) at a magnification of 15,000–40,000×. Images were analyzed with
ImageJ (NIH). To qualify as square arrays, IMP assemblies had to have at least
four IMPs on each side. Because gold particles can be removed from epitopes by
20–30 nm due to the size of the antibody [25], gold particles within 30 nm of an
edge of a square array were considered to recognize AQP4 in square arrays.
2.7. Acyl-Biotinyl Exchange (ABE) Chemistry
The ABE procedure was modified from the original reports [26,27] in the
followingway. Transfected CHO cells were harvested 24 h after transfection, and
the cell pellets were resuspended in homogenization buffer (20 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 5 mM EDTA) containing 10 mM N-ethyl maleimide
(NEM; freshly prepared) and a protease inhibitor cocktail (Nakalai Tesque,
Kyoto, Japan). Membrane fractions were obtained by disrupting cells in a Potter-
Elvehjem homogenizer on ice, and cell debris was removed by centrifugation at
1000 ×g for 10 min. After another centrifugation at 40,000 ×g for 30 min, pellets
were resuspended in solubilization buffer (SB: 1% Triton X-100 in 20 mM Tris–
HCl, pH 7.5, 150 mM NaCl) containing 10 mM NEM and incubated for 30 min
on ice. After centrifugation at 100,000 ×g for 60 min, the supernatants were
incubated overnight at 4 °C with affinity resin that was prepared by using
dimethyl pimelimidate (PIERCE) to cross-link anti-AQP4CTantibody to ProteinG Sepharose (GE Healthcare). After removal of NEM by three washes with SB,
the resin was divided into two aliquots. One aliquot was incubated with 1 M
hydroxylamine (pH 7.5) in 150mMNaCl, 1%TritonX-100 and 1mM iodoactyl-
PEO2-Biotin (PIERCE) for 1 h at room temperature. The other aliquot served as
control and was incubated with 1 M Tris–HCl (pH 7.5) in the same buffer. After
three washes with SB, bound proteins were eluted with 100 mM glycine–HCl
buffer (pH 2.7) containing 1% Triton X-100. The samples were analyzed by
SDS-PAGE and Western blotting using both streptavidin alkaline phosphatase
(avidin-AP) (Promega) and anti-AQP4CT antibody. For immunoprecipitation
and ABE chemistry of AQP4 from brain tissue, a cerebellum was dissected from
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Elvehjem homogenizer on ice with homogenization buffer (7.5 mM sodium
phosphate, pH 7.2, 250 mM sucrose, 5 mM EDTA) containing a protease
inhibitor cocktail. The subsequent procedure was the same as that for the CHO
cells.
2.8. Metabolic labeling
16 h after transfectionCHO cells plated in 60-mmdisheswere preincubated for
30 min in serum-free DMEM containing 10 mg/ml fat-free bovine serum albumin
(SIGMA). [3H]-palmitic acid in ethanol was concentrated in a vacuum centrifuge
so that the final ethanol volumewas 1%of the labelingmedium. Cells were labeled
with 9.25MBq/ml [3H]-palmitic acid for 4 h in preincubation medium. Cells were
harvested and extracted on ice for 30 min with SB containing a protease inhibitor
cocktail. After centrifugation at 14,000 ×g for 10 min, the supernatants were
incubated with anti-AQP4CTantibody overnight at 4 °C. Protein G sepharose was
added to the samples, and after a 1-hour incubation at 4 °C, the resin was washed
with SB. Bound proteins were eluted with SDS-PAGE sample buffer for 10 min at
room temperature and analyzed by SDS-PAGE. For fluorography, gels were
immersed in a fixing solution (25% isopropanol, 10% acetic acid, 65% H2O) forFig. 3. Representative P-face images of plasma membranes of CHO cells transiently
SDS-FRL. (A–C) No square arrays were observed with CHO cells expressing the M
evenly distributed over the entire plasma membranes. (D–F) Square arrays (circles
(F) mutants. Some gold particles labeled square arrays, while others were found outs
particles labeled the square arrays. (H and I) For CHO cells expressing the M21 (H)
bars are 200 nm.30 min, treated with Amplify (GEHealthcare) for 30 min, dried under vacuum and
exposed to BioMax MS film (Kodak) for 2 weeks at −80 °C.
3. Results
3.1. Expression of WT AQP4 and SDS-FRL
The WT aqp4 gene has two translation initiation codons,
encoding methionine residues Met1 and Met23, so that in vivo
two AQP4 isoforms are expressed, AQP4M1 and AQP4M23. To
analyze the formation of square arrays in vitro, we cloned
AQP4M1 and AQP4M23 full-length cDNAs into mammalian
expression vectors. Expression of the two WT AQP4 isoforms
in transfected CHO cells was confirmed by immunoblotting
(Fig. 1A). An antibody against the C-terminus of AQP4 (anti-
AQP4CT) detected protein bands with apparent molecular
weights of 30 kDa and 28 kDa in the solubilized cell lysates,expressing various N-terminal deletion mutants. All replicas were analyzed by
6 (A), M11 (B) and M16 (C) mutants. Almost all immunogold particles were
) were observed with CHO cells expressing the M17 (D), M18 (E) and M19
ide of the arrays. (G) For CHO cells expressing the M20 mutant, almost all gold
and M27 (I) mutants, all gold particles were associated with square arrays. Scale
Fig. 4. WT and deletion mutant AQP4 constructs show different propensities for
square array formation. Bars indicate the mean percentages of the immunogold
labels on square arrays. The numbers of gold particles on square arrays were
divided by the numbers of all gold particles on the P-face in each observed field.
Error bars are ±SD.
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cells transiently expressingAQP4M1 or AQP4M23 by SDS-FRL
using anti-AQP4CT as the first antibody and a 15-nm gold con-
jugated secondary antibody. Since the C-terminus, which is re-
cognized by anti-AQP4CT, is exposed on the cytoplasmic
side, specific immunogold labeling should only be observed on
the P-face of the plasmamembrane.We confirmed that no labeling
was detected with non-transfected CHO cells (Fig. 1B). When the
AQP4M1 isoform of AQP4 was expressed in CHO cells, both
IMPs and immunogold labels were evenly dispersed on the P-face
(Fig. 1C). The E-face showed a concave shape, a lower density of
IMPs than the P-face (Fig. 1D), which is commonly seen for
biological membranes, and no immunogold labels. By contrast,
when the shorter AQP4M23 isoformwas expressed in CHO cells,
square arrays of IMPs were observed on the P-faces, which were
specifically labeled with a high density of immunogold particles
(Fig. 1E). Images of the E-faces revealed the complementary pits
of the square array particles (Fig. 1F) but no immunogold
particles. While the pit-like imprints of the arrays on the E-faces
showed that the square arrays were well ordered, the IMP arrays
seen on the P-faces showed much less order. This observation
indicates that the native arrays are indeed very well ordered and
that the loss of order of the IMP arrays seen on the P-faces is due to
the splitting of the membrane during the freeze fracture procedure.
The size of the square arrays seen on cells transfected with
AQP4M23 varied from ∼1500 nm2 to ∼70,000 nm2 due to
variations in the expression level between cells transiently
expressing AQP4M23. We also established CHO cell lines stably
expressing AQP4M1 and AQP4M23. As with the transient ex-
pressions, AQP4M23 cell lines showed the square arrays whereas
AQP4M1 expressing cell lines did not (data not shown). In the
following freeze fracture studies, we used the transient expression
system and used SDS-FRL to confirm the expression of AQP4.
3.2. Construction and expression of AQP4 mutants with
N-terminal deletions
To identify the regions in the N-terminus that affect the
formation of AQP4 square arrays, we constructed a series of
N-terminal deletion mutants (Fig. 2A). It should be noted that
the M6 construct, for example, lacked the six N-terminal
residues of the AQP4M1 sequence but contained an additional
initiation methionine. All AQP4 deletion mutants were ex-
pressed in transfected cells as determined by immunoblotting
of cell lysates (Fig. 2B), and their correct localization to the
plasma membrane was confirmed by SDS-FRL (Fig. 3A–I).
3.3. SDS-FRL of CHO cells transfected with N-terminal
deletion mutants
When the M6, M11 or M16 constructs were expressed in
CHO cells, no square arrays were observed and the gold labels
were evenly dispersed over the P-faces of the plasma mem-
branes (Fig. 3A–C). By contrast, N-terminal deletion mutants
that were shorter than the M16 construct showed square arrays
with different characteristics. In the case of M17, many of im-
munogold particles labeled the square arrays, but some of goldlabels could also be seen outside the square arrays (Fig. 3D).
This implies that the mutant AQP4 molecules are inclined to
assemble into square arrays but some of the molecules are
detached from the arrays. To estimate the percentage of AQP4
molecules in square arrays, we counted the number of gold
labels on square arrays and compared it with the number of all
gold labels on the P-faces in each image. The mean percentages
and standard deviations (SD) of the labeling in the WT and
mutant AQP4s were graphed in Fig. 4. In the case of AQP4M1,
0%±0% (mean±SD; n=10) of the gold particles were found on
square arrays, whereas for AQP4M23, 95%±5% (n=7) of the
gold particles were localized on square arrays. The M16 mutant
(0%±0%; n=6) behaved like AQP4M1, but in the case of the
M17 mutant, 67%±22% (n=10) of the gold particles localized
to square arrays, demonstrating that this construct can form
square arrays although less efficiently than AQP4M23. The
M18 mutant showed a lower frequency of labeled square arrays,
while most of the gold labels were randomly dispersed over
the P-faces (12%±18%; n=10) (Fig. 3E), and a similar dis-
tribution of the gold particles was observed for the M19 mutant
(21%±18%; n=10) (Fig. 3F). The M20 mutant showed pro-
minent square arrays, but the percentage of gold labels on the
arrays substantially varied between cells (83%±21%; n=10)
(Fig. 3G). As shown by the standard deviations for M17–M20,
the frequency of square array formation and the percentage of
gold labels on square arrays varied between different cells and
fields of view. The variance in the assembly of AQP4 into
square arrays did, however, not correlate with the expression
levels of the AQP4 mutants. In contrast to mutants M17–M20,
the assembly of M21 (96%±5%; n=8) (Fig. 3H) into square
arrays was indistinguishable from AQP4M23. Finally, the M27
mutant (96%±4%; n=9) (Fig. 3I), which lacks most of the
cytoplasmic N-terminal tail of AQP4 whose first transmem-
brane domain starts with Trp30 [18], also formed square arrays
with the same efficiency as AQP4M23. Although the reason for
the variations seen in the M17–M20 mutants in the percentage
of AQP4 molecules assembling into square arrays is currently
Fig. 5. Cysteine substitutions in the N-terminus of full-length AQP4M1 and
SDS-FRL analysis. (A) Alignment of the N-terminal amino acid sequences of
AQP4 from different species, showing that the cysteine residues at positions 13
and 17 are conserved. (B–D) Representative P-face images of plasma mem-
branes of CHO cells transiently expressing AQP4M1 mutants in which one or
both cysteines were substituted by alanine. All replicas were analyzed by SDS-
FRL. (B) CHO cells expressing the single cysteine mutant AQP4M1/C13A
showed no square arrays. (C) CHO cells expressing the other single cysteine
mutant AQP4M1/C17A showed occasional square arrays (circles). (D) CHO
cells expressing the double cysteine mutant AQP4M1/C13,17A revealed that
almost all gold labels localized to square arrays. Scale bars are 200 nm.
Fig. 6. (A) AQP4M1, AQP4M23, AQP4M1/C13A, AQP4M1/C17A or
AQP4M1/C13,17A were expressed in CHO cells, immunoprecipitated and
subjected to ABE chemistry [27]. Non-transfected CHO cells were used as
control. Cells were homogenized, fractionated, solubilized and immunopreci-
pitated in the presence of 10 mM NEM. The immunoprecipitates were bound to
affinity resin, washed without NEM and treated with sulfydryl-reactive bio-
tinylation regent in the presence or absence of hydroxylamine. The eluates were
analyzed on Western blots, which were probed with avidin-AP to detect
biotinylated proteins (upper panel) or anti-AQP4CT antibody (lower panel) to
verify the presence of the various AQP4 constructs. (B) The intrinsic AQP4 was
immunoprecipitated from an adult rat cerebellum and subjected to the same
ABE procedure.
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M17 mutants in terms of their abilities to form square arrays.
These results suggest that disruption of array formation is either
caused by an N-terminus longer than that of the M17 mutant
and/or by specific amino acids in the region from Cys17 to
Ser21 (Cys-Ser-Arg-Glu-Ser).
3.4. Cysteine substitutions in AQP4M1 and SDS-FRL
The cysteine residues at positions 13 and 17 of rat AQP4M1
are conserved in homologs from different species (Fig. 5A), andthe M17 mutant lacked both of these cysteines. To verify the
possible involvement of Cys13 and/or Cys17 in interfering with
the formation of square arrays, we generated AQP4M1 mutants,
in which either one or both cysteine residues were mutated to
alanine. CHO cells transfected with these mutant constructs were
analyzed by SDS-FRL. Electron microscopy showed that the
single cysteine mutant AQP4M1/C13A formed no square arrays
while the other single cysteinemutant, AQP4M1/C17A, formed a
few, small arrays (Fig. 5B and C), respectively. By contrast, the
double cysteine mutant, AQP4M1/C13,17A, formed square ar-
rays very efficiently (Fig. 5D). These observations were con-
firmed by quantifying the percentages of gold particles on square
arrays, whichwere 93%±10% for AQP4M1/C13,17A (n=7), but
only 0%±0% for AQP4M1/C13A (n=10) and 27%±29% for
AQP4M1/M17A (n=9). These results indicate that the presence
of even only one of the two cysteine residues suffices to disrupt
the formation of square arrays.
3.5. The N-terminal cysteines of AQP4M1 are palmitoylated in
CHO cells
Cysteine residues can serve as sites for posttranslational
modifications by fatty acids, but AQP4M1 lacks classical
consensus sequences for both N-terminal myristoylation and
C-terminal prenylation [28,29]. Palmitoylation, another lipid
modification of cysteines, often occurs at the N-terminus of
proteins without well-defined consensus sequences [30]. To
test the possibility that the N-terminal cysteines in AQP4 are
palmitoylated, we immunoprecipitated AQP4 from transfected
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the immunoprecipitates using acyl-biotinyl exchange (ABE)
chemistry [26,27]. In the ABE approach three sequential che-
mical steps are performed to convert palmitoylated proteins to
biotinylated proteins, which can then be identified with high
sensitivity. First, the free thiol groups are alkylated by NEM,
followed by hydroxylamine cleavage of thioester bonds that
link the fatty acids to the proteins. Finally, the newly exposed
free thiols are biotinylated with thiol-specific biotinylation re-
gents. As shown in the upper panel of Fig. 6A, biotinylations
were detected for AQP4M1, AQP4M1/C13A and AQP4M1/
C17A, but not for AQP4M23 or AQP4M1/C13,17A. The pre-
sence of the various AQP4 constructs in the immunoprecipi-
tates was confirmed by immunoblotting with anit-AQP4CT
antibody (Fig. 6A; lower panel). These results show that both
Cys13 and Cys17 carry posttranslational modifications through
thioester bonds. For elucidating whether lipid modification
actually occurs in AQP4M1 in vivo, we immunoprecipitated
AQP4 from the lysate of rat cerebellum and performed the ABE
chemistry. The immunoblot showed two bands of AQP4 cor-
responding to the M1 and M23 isoforms, and the biotinylation
signal was detected at the position of M1 with hydroxylamine
treatment (Fig. 6B). This indicates that AQP4M1 can be
posttranslationally modified in the brain as well as in CHO
cells. To determine whether AQP4M1 expressed in CHO cells
is indeed palmitoylated, we performed metabolic labeling with
[3H]-palmitic acid. Fig. 7A shows a fluorograph of solubilized
AQP4 constructs purified by anti-AQP4CT precipitation. The
corresponding silver-stained gel shows 30-kDa or 28-kDaFig. 7. Metabolic labeling of CHO cells expressing AQP4 constructs. (A) CHO
cells were metabolically labeled with [3H]-palmitic acid and the lysates were
immunoprecipitated with anti-AQP4CT antibody. The fluorography demon-
strates that AQP4M1, AQP4M1/C13A and AQP4M1/C17A are palmitoylated
(arrowhead). Signals at the dye fronts and top of the lanes indicate non-specific
contamination with free [3H]-palmitic acid. (B) The silver stained gel of the
same samples shown in (A) confirms the presence of the various AQP4 cysteine
mutants in the immunoprecipitates (arrowheads). The strong bands at molecular
weights of about 90 kDa and 20 kDa represent the heavy chains (HC) and light
chains (LC) of the polyclonal IgG antibody.bands, verifying that each construct was present in the im-
munoprecipitates (Fig. 7B). The fluorograph revealed the cor-
responding 30-kDa bands only in the samples containing
AQP4M1, AQP4M1/C13A and AQP4M1/C17A. Signals were
also found at the dye fronts and the top of the lanes, as is
commonly seen in fluorography with [3H]-palmitic acid [31].
Quantification of the band intensities by densitometry showed
that the intensity of the 30-kDa band in the AQP4M1 sample
was almost twice as high as those of the bands in the AQP4M1/
C13A and the AQP4M1/C17A samples. These results thus
reveal that in AQP4M1 expressed in CHO cells both Cys13 and
Cys17 are palmitoylated.
4. Discussion
Previous studies established that the two alternative splice
variants of AQP4 have opposing effects on the formation of
square arrays [16,17]. Since the two AQP4 isoforms differ only
in the length of their N-termini, this should be the region that
affects array formation. In this study, we used freeze fracture
electron microscopy of CHO cells transfected with mutant
AQP4s to identify the N-terminal residues that regulate the for-
mation of square arrays.
The systematic deletion of residues in the N-terminus of
AQP4M1 showed that mutants with deletions of less than
seventeen residues behaved like AQP4M1 and did not form
square arrays. The propensity to form square arrays increased
dramatically for the M17 mutant. This finding indicated that
array formation is inhibited either by too long an N-terminus
and/or by Cys17, which was present in the M16 mutant but
lacking in the M17 construct. The possibility of steric hind-
rance due to the mere bulk of the additional N-terminal re-
sidues in AQP4M1 was unlikely to be the cause for its failure
to form arrays, because an additional N-terminal tag of 35 amino
acids did not affect the two-dimensional crystallization of recom-
binant AQP4M23 [18]. We therefore examined the influence of
the two N-terminal cysteine residues of AQP4M1 on array for-
mationwithout changing the length of the N-terminus. The AQP4
double mutant, in which both cysteines were replaced by ala-
nines, was very efficient in forming square arrays in CHO cells.
However, although the cysteines at positions 13 and 17 clearly
have a dramatic effect on array formation, it is unclear why the
M18 and M19 mutants, which are also lacking both N-terminal
cysteines, were not efficient in forming square arrays. Similarly, it
is also not clear why the M20 mutant was not as efficient in array
formation as AQP4M23. As shown in Fig. 4, all the M17, M18,
M19 andM20 showed fluctuated propensities for the formation of
square arrays. The variations seen in these AQP4 deletionmutants
may imply that, rather than one single amino acid residue, the
truncated N-terminus partially containing the region from Ser18
to Ser21 could be involved in the interference with the close
packing of the AQP4 tetramers due to the artificial N-terminal
length or the other unidentified factors.
The M27 construct whose N-terminus is shorter than that of
AQP4M23 did form square arrays. Since this mutant lacks most
of the cytosolic N-terminal residues and the remaining three
residues extending from the first transmembrane domain would
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neighboring tetramers, this result suggests that the N-terminus
itself is not directly involved in interactions that stabilize the
square arrays. This conclusion is consistent with the notion that
square arrays are formed by interactions between the transmem-
brane regions of neighboring AQP4 tetramers [18].
The appearance of square arrays in the AQP4M1/C13,17A
doublemutant indicates that the cysteines are the critical residues
that interfere with array formation. Between the two cysteines
are two proline residues at positions 15 and 16 (Fig. 5A), which
would make this N-terminal region rather flexible, suggesting
that it is not the presence of a rigid domain that interferes with
array formation. Cysteine-directed protein modification was an
alternative possibility how the two cysteines could prevent array
formation. ABE chemistry and metabolic labeling with palmitic
acid showed that both Cys13 and Cys17 were palmitoylated
when AQP4M1 was expressed in CHO cells. AQP4M1 contains
a total of eight cysteine residues, two in the N-terminus, five
scattered throughout the transmembrane helices and one in
the C-terminus, adjacent to the sixth transmembrane domain.
Since no palmitic acid signal was observed with the AQP4M1/
C13,17A double mutant, the two N-terminal cysteines are the
only palmitoylation sites in AQP4. As is the case for AQP4,
palmitoylation often occurs at cysteine residues up to 20 amino
acids from the N-terminus [32], close to basic and hydrophobic
residues [33]. For most transmembrane proteins, however, such
as G-protein coupled receptors [30], AMPA receptors [34], and
synaptotagmin [35], palmitoylation occurs at cytosolic cysteines
at the roots of intracellular loops and/or just downstream of the
last transmembrane domain [33]. Only very few transmembrane
proteins, one example would be tetraspanin CD151 [36], have
been reported to be N-terminally palmitoylated like AQP4.
In AQP4M1, the double cysteine substitution resulted in the
loss of palmitoylation and simultaneously the mutant became
efficient in forming square arrays. These results suggest that
the N-terminal palmitoylation is a crucial factor in preventing
AQP4M1 to form square arrays. Palmitoylation of cysteine re-
sidues typically facilitates the interactions of proteins with the
lipid membrane and modulates their functions [30,33]. Our
previously determined density map of AQP4M23 suggested that
the N-terminus is located close to the area where four adjacent
tetramers come together in the square arrays [18]. Attachment of
the N-terminus to the lipid bilayer by palmitoylation could
thus cause steric hindrances that would prevent AQP4M1
tetramers to come close enough to each other to form an array.
This mechanism would constitute an unprecedented function of
palmitoylation in the regulation of interactions between mem-
brane proteins. However we cannot conclude that the palmitoy-
lation is the sole determinant for the destabilization of the square
arrays, because we could so far get less clear results in our
attempt to confirm the direct effect for the array disruption by
the palmitoylation itself while leaving the two cysteines in
place. In our preliminary experiments of the AQPM1 transfected
cells, the effect of 2-bromopalmitate, an inhibitor that blocks
palmitate incorporation into proteins [37], could not give clear
arrays while some aggregation of IMPs on the P-faces and small
pit-type arrays on the E-faces were observed (data not shown).Therefore, much more studies for the complete inhibition of
palmitoylation are required. These experimental results together
with fluctuated propensities of the array formation by the
mutants of M17, M18, M19 and M20 as shown in Fig. 4
suggested that the other unknown factors in the N-terminus of
AQP4M1 could not be excluded, although N-terminal palmi-
toylation is the crucial determinant for the array deformation.
It should be noted that the formation of square arrays may
be regulated by more than one mechanism, because palmitoyla-
tion is labile and reversible depending on cellular conditions and
physiological signaling. The expression ratio of AQP4M1 and
AQP4M23 would also determine the potential of AQP4 to be
palmitoylated. Differential palmitoylation due to alternative spli-
cing has been reported for some cytosolic proteins in neurons
[38–40], altering their auxiliary functions and trafficking to the
plasma membrane. AMPA receptors have two palmitoylation
sites, one in the second transmembrane domain and one in the
C-terminal region, and the palmitoylation state may modulate
the trafficking of these receptors [34,41]. In the case of AQP4,
there is no evidence that AQP4M1 and AQP4M23 are trafficked
differently, and the polarized anchoring of AQP4 to astrocyte
endfeet is likely due to its C-terminal PDZ binding domain [6,15].
However, the extent and dynamics of palmitoylation of AQP4M1
in vivo is unknown. It may thus be that AQP4M1 in the plasma
membrane is not palmitoylated, and regulated palmitoylation of
AQP4M1 could then be a mechanism to disrupt square arrays.
This model could explain how square arrays can be rapidly
disassembled after circulatory arrest [13]. It cannot be excluded,
however, that in vivo square arrays contain a certain amount of
palmitoylated AQP4M1, which could then play a role in pro-
viding suitable sizes of the arrays for rapid disassembly by the
other mechanisms, as previously proposed [16]. In this case,
palmitoylation may function as a sorting signal of AQP4M1/
AQP4M23 heterotetramer clusters to specific membrane do-
mains, as has been reported for PSD-95 and GAP-43 [42], or to
the membrane microdomains such as lipid rafts.
Although our studies remain uncertain whether palmitoyla-
tion actually occurs in vivo and at the same Cys13 and Cys17 as
in CHO cells, the biochemical analyses of the brain tissue by
ABE chemistry showed that some kind of fatty acylation of the
AQP4 occurred also in vivo, implying the possibility that some
extent of palmitoylated AQP4 is present in the brain (Fig. 6B).
Further studies are needed to test the hypotheses described above
and to relate the palmitoylation state of AQP4 in vivo with
morphological and functional differences between the two
AQP4 isoforms. The palmitoylation of AQP4 is the first finding
of lipid modification on water channels, and encourages further
studies for establishing whether other water channels also con-
tain lipid modifications.
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